—
C+
C+ The full Closelook — membership. Open the C+ overview

Orion Oyj B (ORNBV.HE) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Orion Oyj B

ORNBV.HE in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Orion Oyj develops, makes and sells human and veterinary medicines together with active pharmaceutical ingredients, headquartered in Espoo, Finland. It sells prescription drugs for prostate cancer, Parkinson's disease, asthma and pain, plus veterinary treatments and self-care products such as supplements and skincare, marketed across Nordic, European and international markets.
Where it sits in the stack
Orion sits outside Rubin, our index tracking the AI build-out; it belongs instead to the wider Healthcare sector, in the Drug Manufacturers - General industry line of our coverage.
Who it is priced against
Closelook's peer group for Orion is not defined in our coverage; the market sometimes names Novo Nordisk as a comparator given its Nordic pharmaceutical scale.
Why Closelook tracks it
Orion is not a constituent of Rubin or any other Closelook index, but it does carry a score, with momentum standing as its most active module; the diary has not yet quoted it in an edition.
What the diary watches
The diary watches whether momentum readings hold as Orion's oncology and respiratory lines meet generic competition and as its licensing agreements, such as the one with Bayer, develop.

Orion Oyj B (ORNBV.HE) trades on the HE exchange in Finland, classified under Healthcare.

The Closelook company score reads 61/100 composite (momentum 77, quality 82, valuation 35) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for ORNBV.HE, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against Healthcare · 8 names with week and year-to-date

Peer group

Healthcare

Scored names in the same sector from the Closelook universe.

Compared against ORNBV.HE on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sector × region Health care in Europe: +1.1% week · −3.6% month · +0.3% quarter · −6.5% yearThe Sector Engine cell this name lives in, from EXV4.XETRA; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-09-16
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is Orion Oyj B (ORNBV.HE)?

Orion Oyj B trades as ORNBV.HE on the HE exchange (Finland) and is classified under Healthcare in the Closelook research universe, as of the registry build of 2026-09-18.

Is ORNBV.HE in a Closelook index?

Not currently — Orion Oyj B is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-18.

What is Orion Oyj B's Closelook composite score?

61 out of 100, with momentum 77, quality 82 and valuation 35 sub-scores, as of 2026-09-18. Scores are Closelook's own research readings, not ratings or investment advice.

Where does ORNBV.HE trade against its moving averages?

Uptrend stack intact: Trades +4.2% vs the 50-day and +15.6% vs the 200-day average, 1.4% below the 52-week high and +46.5% off the 52-week low. Computed from daily closes. As of 2026-09-17 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Orion Oyj B do?

Orion Oyj develops, makes and sells human and veterinary medicines together with active pharmaceutical ingredients, headquartered in Espoo, Finland. It sells prescription drugs for prostate cancer, Parkinson's disease, asthma and pain, plus veterinary treatments and self-care products such as supplements and skincare, marketed across Nordic, European and international markets. Closelook's peer group for Orion is not defined in our coverage; the market sometimes names Novo Nordisk as a comparator given its Nordic pharmaceutical scale.

Where does Orion Oyj B sit in the AI build-out?

Orion sits outside Rubin, our index tracking the AI build-out; it belongs instead to the wider Healthcare sector, in the Drug Manufacturers - General industry line of our coverage. Orion is not a constituent of Rubin or any other Closelook index, but it does carry a score, with momentum standing as its most active module; the diary has not yet quoted it in an edition.

What does this page show?

A live price chart with SMA overlays and drawing tools for ORNBV.HE, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe